Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CMS In Brief

This article was originally published in The Gray Sheet

Executive Summary

News from the Medicare agency includes updates on the DME competitive bidding program, overpayment recoveries and obesity screening.

You may also be interested in...

News In Brief

Given Imaging swallows SmartPill Corp. in $6 million acquisition deal. AdvaMed opens jobs program for veterans. Medical devices in space get funding. More news briefs.

As DME Bidding Program Rolls Ahead, Auction Researchers Call It “Fatally Flawed”

CMS is moving forward as planned with a 10-fold expansion in the number of metropolitan areas where Medicare will pay for popular durable medical equipment at reduced, competitively bid rates.

Access To Diabetic Test Strips Jeopardized In CMS Competitive Bidding Areas

A new program to cut Medicare spending could threaten access to medical products that doctors recommend and patients favor, according to early indicators that emerged last week.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts